{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:06:46Z","timestamp":1792649206616,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK129241"],"award-info":[{"award-number":["DK129241"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK126662"],"award-info":[{"award-number":["DK126662"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK059597"],"award-info":[{"award-number":["DK059597"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK058816"],"award-info":[{"award-number":["DK058816"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["PR221810"],"award-info":[{"award-number":["PR221810"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["PR221810"],"award-info":[{"award-number":["PR221810"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-65997-1","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T09:37:36Z","timestamp":1765445856000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["In vivo base editing rescues ADPKD in a humanized mouse model"],"prefix":"10.1038","volume":"16","author":[{"given":"Alice Shasha","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7460-0776","authenticated-orcid":false,"given":"Linda Xiaoyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie Xia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5928-9820","authenticated-orcid":false,"given":"James P.","family":"Calvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8135-342X","authenticated-orcid":false,"given":"Xiaogang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"65997_CR1","doi-asserted-by":"publisher","first-page":"922428","DOI":"10.3389\/fmolb.2022.922428","volume":"9","author":"E Agborbesong","year":"2022","unstructured":"Agborbesong, E., Li, L. X., Li, L. & Li, X. Molecular mechanisms of epigenetic regulation, inflammation, and cell death in ADPKD. Front. Mol. Biosci. 9, 922428 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"65997_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/ki.2009.128","volume":"76","author":"VE Torres","year":"2009","unstructured":"Torres, V. E. & Harris, P. C. Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int. 76, 149\u2013168 (2009).","journal-title":"Kidney Int."},{"key":"65997_CR3","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1053\/j.ajkd.2015.07.037","volume":"67","author":"FT Chebib","year":"2016","unstructured":"Chebib, F. T. & Torres, V. E. Autosomal dominant polycystic kidney disease: core curriculum 2016. Am. J. Kidney Dis. 67, 792\u2013810 (2016).","journal-title":"Am. J. Kidney Dis."},{"key":"65997_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nrneph.2009.13","volume":"5","author":"T Ecder","year":"2009","unstructured":"Ecder, T. & Schrier, R. W. Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease. Nat. Rev. Nephrol. 5, 221\u2013228 (2009).","journal-title":"Nat. Rev. Nephrol."},{"key":"65997_CR5","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1681\/ASN.2012070650","volume":"24","author":"E Cornec-Le Gall","year":"2013","unstructured":"Cornec-Le Gall, E. et al. Type of PKD1 mutation influences renal outcome in ADPKD. J. Am. Soc. Nephrology: JASN 24, 1006 (2013).","journal-title":"J. Am. Soc. Nephrology: JASN"},{"key":"65997_CR6","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.kint.2024.04.017","volume":"106","author":"JX Zhou","year":"2024","unstructured":"Zhou, J. X. et al. DNA methyltransferase 1 (DNMT1) promotes cyst growth and epigenetic age acceleration in autosomal dominant polycystic kidney disease. Kidney Int. 106, 258\u2013272 (2024).","journal-title":"Kidney Int."},{"key":"65997_CR7","doi-asserted-by":"crossref","unstructured":"Mao, X. et al. Cellular senescence and its association with aldose reductase promote cyst growth in autosomal dominant polycystic kidney disease. Kidney Int. 108, 811\u2013826 (2025).","DOI":"10.1016\/j.kint.2025.05.027"},{"key":"65997_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41551-019-0501-5","volume":"4","author":"JM Levy","year":"2020","unstructured":"Levy, J. M. et al. Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses. Nat. Biomed. Eng. 4, 97\u2013110 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"65997_CR9","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. & Liu, D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420\u2013424 (2016).","journal-title":"Nature"},{"key":"65997_CR10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli, N. M. et al. Programmable base editing of A\u2022 T to G\u2022 C in genomic DNA without DNA cleavage. Nature 551, 464\u2013471 (2017).","journal-title":"Nature"},{"key":"65997_CR11","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41586-020-03086-7","volume":"589","author":"LW Koblan","year":"2021","unstructured":"Koblan, L. W. et al. In vivo base editing rescues Hutchinson\u2013Gilford progeria syndrome in mice. Nature 589, 608\u2013614 (2021).","journal-title":"Nature"},{"key":"65997_CR12","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41591-022-02190-7","volume":"29","author":"D Reichart","year":"2023","unstructured":"Reichart, D. et al. Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice. Nat. Med. 29, 412\u2013421 (2023).","journal-title":"Nat. Med."},{"key":"65997_CR13","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1172\/JCI64313","volume":"122","author":"K Hopp","year":"2012","unstructured":"Hopp, K. et al. Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity. J. Clin. Investig. 122, 4257\u20134273 (2012).","journal-title":"J. Clin. Investig."},{"key":"65997_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41589-022-01163-8","volume":"19","author":"L Chen","year":"2023","unstructured":"Chen, L. et al. Engineering a precise adenine base editor with minimal bystander editing. Nat. Chem. Biol. 19, 101\u2013110 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"65997_CR15","doi-asserted-by":"publisher","first-page":"20969","DOI":"10.1073\/pnas.1906843116","volume":"116","author":"Y Tan","year":"2019","unstructured":"Tan, Y. et al. Rationally engineered Staphylococcus aureus Cas9 nucleases with high genome-wide specificity. Proc. Natl Acad. Sci. 116, 20969\u201320976 (2019).","journal-title":"Proc. Natl Acad. Sci."},{"key":"65997_CR16","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1126\/science.aas9129","volume":"361","author":"H Nishimasu","year":"2018","unstructured":"Nishimasu, H. et al. Engineered CRISPR-Cas9 nuclease with expanded targeting space. Science 361, 1259\u20131262 (2018).","journal-title":"Science"},{"key":"65997_CR17","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41587-020-0412-8","volume":"38","author":"SM Miller","year":"2020","unstructured":"Miller, S. M. et al. Continuous evolution of SpCas9 variants compatible with non-G PAMs. Nat. Biotechnol. 38, 471\u2013481 (2020).","journal-title":"Nat. Biotechnol."},{"key":"65997_CR18","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1038\/nm1675","volume":"13","author":"K Piontek","year":"2007","unstructured":"Piontek, K., Menezes, L. F., Garcia-Gonzalez, M. A., Huso, D. L. & Germino, G. G. A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1. Nat. Med. 13, 1490\u20131495 (2007).","journal-title":"Nat. Med."},{"key":"65997_CR19","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1172\/JCI76972","volume":"125","author":"VG Gainullin","year":"2015","unstructured":"Gainullin, V. G., Hopp, K., Ward, C. J., Hommerding, C. J. & Harris, P. C. Polycystin-1 maturation requires polycystin-2 in a dose-dependent manner. J. Clin. Investig. 125, 607\u2013620 (2015).","journal-title":"J. Clin. Investig."},{"key":"65997_CR20","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1681\/ASN.V881292","volume":"8","author":"AB Chapman","year":"1997","unstructured":"Chapman, A. B. et al. Left ventricular hypertrophy in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 8, 1292\u20131297 (1997).","journal-title":"J. Am. Soc. Nephrol."},{"key":"65997_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109730","volume":"74","author":"DJ Atwood","year":"2020","unstructured":"Atwood, D. J. et al. Increased mTOR and suppressed autophagic flux in the heart of a hypomorphic Pkd1 mouse model of autosomal dominant polycystic kidney disease. Cell. Signal. 74, 109730 (2020).","journal-title":"Cell. Signal."},{"key":"65997_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc8226","volume":"15","author":"WY Ding","year":"2023","unstructured":"Ding, W. Y. et al. Adeno-associated virus gene therapy prevents progression of kidney disease in genetic models of nephrotic syndrome. Sci. Transl. Med. 15, eabc8226 (2023).","journal-title":"Sci. Transl. Med."},{"key":"65997_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54475-9","volume":"15","author":"T Furusho","year":"2024","unstructured":"Furusho, T. et al. Enhancing gene transfer to renal tubules and podocytes by context-dependent selection of AAV capsids. Nat. Commun. 15, 10728 (2024).","journal-title":"Nat. Commun."},{"key":"65997_CR24","doi-asserted-by":"crossref","unstructured":"Wu, G. et al. Adeno-associated virus\u2013based gene therapy treats inflammatory kidney disease in mice. J. Clin. Investig. 134, e174722 (2024).","DOI":"10.1172\/JCI174722"},{"key":"65997_CR25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41392-025-02336-2","volume":"10","author":"N Gupta","year":"2025","unstructured":"Gupta, N., Zhang, K., Sabbisetti, V., Shu, J. & Morizane, R. AAV for gene therapy drives a nephrotoxic response via NF\u03baB in kidney organoids. Signal Transduct. Target. Ther. 10, 252 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"65997_CR26","doi-asserted-by":"crossref","unstructured":"Igarashi, P. et al. Ksp-cadherin gene promoter. II. Kidney-specific activity in transgenic mice. Am. J. Physiol.-Renal Physiol. 277, F599\u2013610 (1999).","DOI":"10.1152\/ajprenal.1999.277.4.F599"},{"key":"65997_CR27","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1093\/nar\/gkad1225","volume":"52","author":"J Mononen","year":"2024","unstructured":"Mononen, J. et al. Genetic variation is a key determinant of chromatin accessibility and drives differences in the regulatory landscape of C57BL\/6J and 129S1\/SvImJ mice. Nucleic Acids Res. 52, 2904\u20132923 (2024).","journal-title":"Nucleic Acids Res."},{"key":"65997_CR28","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.kint.2021.01.028","volume":"99","author":"J Arroyo","year":"2021","unstructured":"Arroyo, J. et al. The genetic background significantly impacts the severity of kidney cystic disease in the Pkd1RC\/RC mouse model of autosomal dominant polycystic kidney disease. Kidney Int. 99, 1392\u20131407 (2021).","journal-title":"Kidney Int."},{"key":"65997_CR29","unstructured":"Lala, V., Zubair, M. & Minter, D. Liver function tests. StatPearls (2023)."},{"key":"65997_CR30","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","volume":"9","author":"NR Sproston","year":"2018","unstructured":"Sproston, N. R. & Ashworth, J. J. Role of C-reactive protein at sites of inflammation and infection. Front. Immunol. 9, 754 (2018).","journal-title":"Front. Immunol."},{"key":"65997_CR31","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41591-022-02176-5","volume":"29","author":"AC Chai","year":"2023","unstructured":"Chai, A. C. et al. Base editing correction of hypertrophic cardiomyopathy in human cardiomyocytes and humanized mice. Nat. Med. 29, 401\u2013411 (2023).","journal-title":"Nat. Med."},{"key":"65997_CR32","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/j.ymthe.2024.05.027","volume":"32","author":"R Gopalappa","year":"2024","unstructured":"Gopalappa, R. et al. In vivo adenine base editing rescues adrenoleukodystrophy in a humanized mouse model. Mol. Ther. 32, 2190\u20132206 (2024).","journal-title":"Mol. Ther."},{"key":"65997_CR33","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/ki.2012.446","volume":"83","author":"KI Swenson-Fields","year":"2013","unstructured":"Swenson-Fields, K. I. et al. Macrophages promote polycystic kidney disease progression. Kidney Int 83, 855\u2013864 (2013).","journal-title":"Kidney Int"},{"key":"65997_CR34","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1681\/ASN.2011010084","volume":"22","author":"A Karihaloo","year":"2011","unstructured":"Karihaloo, A. et al. Macrophages promote cyst growth in polycystic kidney disease. J. Am. Soc. Nephrology: JASN 22, 1809\u20131814 (2011).","journal-title":"J. Am. Soc. Nephrology: JASN"},{"key":"65997_CR35","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1172\/JCI80467","volume":"125","author":"L Chen","year":"2015","unstructured":"Chen, L. et al. Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease. J. Clin. Investig. 125, 2399\u20132412 (2015).","journal-title":"J. Clin. Investig."},{"key":"65997_CR36","doi-asserted-by":"publisher","first-page":"F227","DOI":"10.1152\/ajprenal.00452.2021","volume":"323","author":"LX Li","year":"2022","unstructured":"Li, L. X. et al. Cross talk between lysine methyltransferase Smyd2 and TGF-\u03b2-Smad3 signaling promotes renal fibrosis in autosomal dominant polycystic kidney disease. Am. J. Physiol.-Ren. Physiol. 323, F227\u2013F242 (2022).","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"65997_CR37","doi-asserted-by":"crossref","unstructured":"Zhou, J.X. et al. CD74 Promotes Cyst Growth and Renal Fibrosis in Autosomal Dominant Polycystic Kidney Disease. Cells 13 (2024).","DOI":"10.3390\/cells13060489"},{"key":"65997_CR38","doi-asserted-by":"crossref","unstructured":"Sagar, P. S. & Rangan, G. K. Cardiovascular Manifestations and Management in Autosomal Dominant Polycystic Kidney Disease. Kidney International Reports, (2023).","DOI":"10.1016\/j.ekir.2023.07.017"},{"key":"65997_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/cardiogenetics11020006","volume":"11","author":"L Spinelli","year":"2021","unstructured":"Spinelli, L., Giugliano, G. & Esposito, G. Cardiac involvement in autosomal dominant polycystic kidney disease. Cardiogenetics 11, 39\u201349 (2021).","journal-title":"Cardiogenetics"},{"key":"65997_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23996-y","volume":"12","author":"L Xu","year":"2021","unstructured":"Xu, L. et al. Efficient precise in vivo base editing in adult dystrophic mice. Nat. Commun. 12, 3719 (2021).","journal-title":"Nat. Commun."},{"key":"65997_CR41","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.ymthe.2020.07.021","volume":"28","author":"YK Jeong","year":"2020","unstructured":"Jeong, Y. K., Song, B. & Bae, S. Current status and challenges of DNA base editing tools. Mol. Ther. 28, 1938\u20131952 (2020).","journal-title":"Mol. Ther."},{"key":"65997_CR42","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1126\/science.ade1105","volume":"379","author":"S Lebek","year":"2023","unstructured":"Lebek, S. et al. Ablation of CaMKII\u03b4 oxidation by CRISPR-Cas9 base editing as a therapy for cardiac disease. Science 379, 179\u2013185 (2023).","journal-title":"Science"},{"key":"65997_CR43","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1161\/CIRCULATIONAHA.123.065624","volume":"149","author":"M Qi","year":"2024","unstructured":"Qi, M. et al. In vivo base editing of Scn5a rescues type 3 long QT syndrome in mice. Circulation 149, 317\u2013329 (2024).","journal-title":"Circulation"},{"key":"65997_CR44","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1016\/j.ymthe.2022.07.010","volume":"30","author":"T Tu","year":"2022","unstructured":"Tu, T. et al. A precise and efficient adenine base editor. Mol. Ther. 30, 2933\u20132941 (2022).","journal-title":"Mol. Ther."},{"key":"65997_CR45","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ekir.2019.12.007","volume":"5","author":"IY Kuo","year":"2020","unstructured":"Kuo, I. Y. & Chapman, A. B. Polycystins, ADPKD, and cardiovascular disease. Kidney Int. Rep. 5, 396\u2013406 (2020).","journal-title":"Kidney Int. Rep."},{"key":"65997_CR46","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1681\/ASN.2017010084","volume":"28","author":"PK Judge","year":"2017","unstructured":"Judge, P. K. et al. Biliary tract and liver complications in polycystic kidney disease. J. Am. Soc. Nephrol. 28, 2738\u20132748 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"65997_CR47","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1126\/science.aav9973","volume":"364","author":"E Zuo","year":"2019","unstructured":"Zuo, E. et al. Cytosine base editor generates substantial off-target single-nucleotide variants in mouse embryos. Science 364, 289\u2013292 (2019).","journal-title":"Science"},{"key":"65997_CR48","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1126\/science.aaw7166","volume":"364","author":"S Jin","year":"2019","unstructured":"Jin, S. et al. Cytosine, but not adenine, base editors induce genome-wide off-target mutations in rice. Science 364, 292\u2013295 (2019).","journal-title":"Science"},{"key":"65997_CR49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41392-019-0044-y","volume":"4","author":"H Xin","year":"2019","unstructured":"Xin, H., Wan, T. & Ping, Y. Off-Targeting of Base Editors: BE3 but not ABE induces substantial off-target single nucleotide variants. Signal Transduct. Target. Ther. 4, 9 (2019).","journal-title":"Signal Transduct. Target. Ther."},{"key":"65997_CR50","doi-asserted-by":"crossref","unstructured":"Konkalmatt, P.R. et al. Renal rescue of dopamine D2 receptor function reverses renal injury and high blood pressure. JCI insight 1 (2016).","DOI":"10.1172\/jci.insight.85888"},{"key":"65997_CR51","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1089\/hum.2019.127","volume":"30","author":"JD Rubin","year":"2019","unstructured":"Rubin, J. D., Nguyen, T. V., Allen, K. L., Ayasoufi, K. & Barry, M. A. Comparison of gene delivery to the kidney by adenovirus, adeno-associated virus, and lentiviral vectors after intravenous and direct kidney injections. Hum. gene Ther. 30, 1559\u20131571 (2019).","journal-title":"Hum. gene Ther."},{"key":"65997_CR52","doi-asserted-by":"crossref","unstructured":"Furusho, T. et al. Enhancing gene transfer to renal tubules and podocytes by context-dependent selection of AAV capsids. bioRxiv, 2023.2007. 2028.548760 (2023).","DOI":"10.1101\/2023.07.28.548760"},{"key":"65997_CR53","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s42003-021-02730-w","volume":"4","author":"N Daneshgar","year":"2021","unstructured":"Daneshgar, N. et al. Metabolic derangement in polycystic kidney disease mouse models is ameliorated by mitochondrial-targeted antioxidants. Commun. Biol. 4, 1200 (2021).","journal-title":"Commun. Biol."},{"key":"65997_CR54","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ymthe.2023.01.010","volume":"31","author":"M Schulz","year":"2023","unstructured":"Schulz, M. et al. Binding and neutralizing anti-AAV antibodies: Detection and implications for rAAV-mediated gene therapy. Mol. Ther. 31, 616\u2013630 (2023).","journal-title":"Mol. Ther."},{"key":"65997_CR55","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fnana.2014.00042","volume":"8","author":"DJ Schuster","year":"2014","unstructured":"Schuster, D. J. et al. Biodistribution of adeno-associated virus serotype 9 (AAV9) vector after intrathecal and intravenous delivery in mouse. Front. Neuroanat. 8, 42 (2014).","journal-title":"Front. Neuroanat."},{"key":"65997_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.1051559","volume":"13","author":"BS Hollidge","year":"2022","unstructured":"Hollidge, B. S. et al. Kinetics and durability of transgene expression after intrastriatal injection of AAV9 vectors. Front. Neurol. 13, 1051559 (2022).","journal-title":"Front. Neurol."},{"key":"65997_CR57","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.ymthe.2022.03.004","volume":"30","author":"M Muhuri","year":"2022","unstructured":"Muhuri, M., Levy, D. I., Schulz, M., McCarty, D. & Gao, G. Durability of transgene expression after rAAV gene therapy. Mol. Ther. 30, 1364\u20131380 (2022).","journal-title":"Mol. Ther."},{"key":"65997_CR58","doi-asserted-by":"crossref","unstructured":"Schindeler, A. et al. In vivo precision base editing to rescue mouse models of disease. Mol. Ther. Nucleic Acids. 36, 102622 (2025).","DOI":"10.1016\/j.omtn.2025.102622"},{"key":"65997_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01925-5","volume":"23","author":"M Chehelgerdi","year":"2024","unstructured":"Chehelgerdi, M. et al. Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy. Mol. cancer 23, 9 (2024).","journal-title":"Mol. cancer"},{"key":"65997_CR60","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00109-020-01893-z","volume":"98","author":"HA Han","year":"2020","unstructured":"Han, H. A., Pang, J. K. S. & Soh, B.-S. Mitigating off-target effects in CRISPR\/Cas9-mediated in vivo gene editing. J. Mol. Med. 98, 615\u2013632 (2020).","journal-title":"J. Mol. Med."},{"key":"65997_CR61","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41434-023-00405-1","volume":"32","author":"D Stone","year":"2025","unstructured":"Stone, D., Aubert, M. & Jerome, K. R. Adeno-associated virus vectors and neurotoxicity\u2014lessons from preclinical and human studies. Gene Ther. 32, 60\u201373 (2025).","journal-title":"Gene Ther."},{"key":"65997_CR62","doi-asserted-by":"publisher","first-page":"1065377","DOI":"10.3389\/fmed.2022.1065377","volume":"9","author":"P Zarghamian","year":"2023","unstructured":"Zarghamian, P., Klermund, J. & Cathomen, T. Clinical genome editing to treat sickle cell disease\u2014a brief update. Front. Med. 9, 1065377 (2023).","journal-title":"Front. Med."},{"key":"65997_CR63","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/s41587-020-0453-z","volume":"38","author":"MF Richter","year":"2020","unstructured":"Richter, M. F. et al. Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity. Nat. Biotechnol. 38, 883\u2013891 (2020).","journal-title":"Nat. Biotechnol."},{"key":"65997_CR64","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1172\/JCI64401","volume":"123","author":"X Zhou","year":"2013","unstructured":"Zhou, X. et al. Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease. J. Clin. Investig. 123, 3084\u20133098 (2013).","journal-title":"J. Clin. Investig."},{"key":"65997_CR65","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s40268-024-00483-5","volume":"24","author":"TJ Kottom","year":"2024","unstructured":"Kottom, T. J. et al. Preclinical and Toxicology Assessment of ALW-II-41-27, an Inhibitor of the Eph Receptor A2 (EphA2). Drugs RD 24, 425\u2013434 (2024).","journal-title":"Drugs RD"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65997-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65997-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65997-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:03:12Z","timestamp":1766073792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65997-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["65997"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-65997-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"23 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11212"}}